论文信息 - Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndrome - 字舞流文

Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndrome

M. Zibelman | A. Kutikov | M. Bartel | Christopher Schaefer | S. Masic | K. Zarrabi

[1] R.C.E. van Velthoven,et al. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial , 2019, JAMA oncology.

[2] K. Bensalah,et al. Sunitinib Alone or after Nephrectomy in Metastatic Renal‐Cell Carcinoma , 2018, The New England journal of medicine.

[3] S. Alazemi,et al. Stauffer’s syndrome variant with cholestatic jaundice , 2006, Journal of General Internal Medicine.

[4] J. Blay,et al. Role of interleukin‐6 in the paraneoplastic inflammatory syndrome associated with renal‐cell carcinoma , 1997, International journal of cancer.